vaginal lactobacilli l crispatus atcc (ATCC)
Structured Review
Vaginal Lactobacilli L Crispatus Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 140 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vaginal+lactobacilli/Lactobacillus+crispatus+(Brygoo+and+Aladame)+Moore+and+Holdeman/pm39696572-216-6-10
Average 95 stars, based on 140 article reviews
Images
Related Articles
Proximity Ligation Assay:Article Title: Electrospinning technologies for the delivery of Biopharmaceuticals: Current status and future trends. Article Snippet: .. - 30 - IGF-1 (Mw: 7.65kDa) HAMA/P CL Dural substitutes [238] IGF-2 (Mw: 7.5kDa) Chitosan/ PCL Wound healing [239] VEGF-A (Mw: 45kDa) PCL Neuroprotective Effects [240] TGF-β (Mw: 25kDa) PCL/PLA Tissue engineering (cardiac repair) [241] IGF-1,VEGF (Mw: 45kDa) Silk Fibroin Bone defect repair and angiogenesis [242] TGFβ3 (Mw: 25.5kDa) PCL Tissue engineering (cartilage) [243] VEGF PCL/Gela tin Tissue engineering (Patellar Ligament Regeneration) [244] SDF-1α (Mw: 8.0kDa) PLGA Trap the residual GBM cells in the brain [245] - 31 - SDF-1α/CXCL12 (Mw: 10kDa) PLA Neural Regeneration Therapy [246] TGF-β3 and SDF-1α Hyaluroni c acid Tissue engineering (articular cartilage repair) [247] Thyroid hormone triiodothyronine (Mw: 0,65kDa) (with ibuprofen) PLGA/PL LA Treatment of Acute Injuries of the Central Nervous System [248] Melatonin (Mw: 0.23kDa) PCL Tissue engineering (tendon) [249] Melatonin Chitosan/ PCL/PVA Wound healing [250] Insulin (Mw: 5.81kDa) PCL/PEO Wound healing [251] F(ab) (Mw: 50kDa) PVP Inflammatory oral mucosal disease [252] Bevacizumab (Mw: 149kDa) PCL Age-related macular degeneration [253] - 32 - Bevacizumab PCL/Gela tin Age-related macular degeneration [254] Infliximab (Mw: 144 kDa) HP-β-CD Treatment of Crohn’s disease [171] plasmid DNA (Mw: around 2000kDa) GelatinCollagenPEG Gene therapy [255] plasmid DNA Gelatin Gene therapy [256] miR‐132/miR‐222/miR‐431 (Mw: 7.14-8.5kDa) Collagen Promote Axon Regeneration [257] miR‐132/miR‐31 (Mw: 7.14-8.5kDa) PVA Wound healing [258] Nucleic acids miR‐181a/b‐1 (Mw: 7.14-8.5kDa) PEG/PLG A Tissue engineering (osteogenesis of human mesenchymal stem cells) [259] - 33 - Antisense oligonucleotide HP-β-CD Gene suppression [260 ] Escherichia coli strain Nissle 1917 PVA/CA Probiotics delivery (gut) [261] Plasmid Preparation:Article Title: Electrospinning technologies for the delivery of Biopharmaceuticals: Current status and future trends. Article Snippet: .. - 30 - IGF-1 (Mw: 7.65kDa) HAMA/P CL Dural substitutes [238] IGF-2 (Mw: 7.5kDa) Chitosan/ PCL Wound healing [239] VEGF-A (Mw: 45kDa) PCL Neuroprotective Effects [240] TGF-β (Mw: 25kDa) PCL/PLA Tissue engineering (cardiac repair) [241] IGF-1,VEGF (Mw: 45kDa) Silk Fibroin Bone defect repair and angiogenesis [242] TGFβ3 (Mw: 25.5kDa) PCL Tissue engineering (cartilage) [243] VEGF PCL/Gela tin Tissue engineering (Patellar Ligament Regeneration) [244] SDF-1α (Mw: 8.0kDa) PLGA Trap the residual GBM cells in the brain [245] - 31 - SDF-1α/CXCL12 (Mw: 10kDa) PLA Neural Regeneration Therapy [246] TGF-β3 and SDF-1α Hyaluroni c acid Tissue engineering (articular cartilage repair) [247] Thyroid hormone triiodothyronine (Mw: 0,65kDa) (with ibuprofen) PLGA/PL LA Treatment of Acute Injuries of the Central Nervous System [248] Melatonin (Mw: 0.23kDa) PCL Tissue engineering (tendon) [249] Melatonin Chitosan/ PCL/PVA Wound healing [250] Insulin (Mw: 5.81kDa) PCL/PEO Wound healing [251] F(ab) (Mw: 50kDa) PVP Inflammatory oral mucosal disease [252] Bevacizumab (Mw: 149kDa) PCL Age-related macular degeneration [253] - 32 - Bevacizumab PCL/Gela tin Age-related macular degeneration [254] Infliximab (Mw: 144 kDa) HP-β-CD Treatment of Crohn’s disease [171] plasmid DNA (Mw: around 2000kDa) GelatinCollagenPEG Gene therapy [255] plasmid DNA Gelatin Gene therapy [256] miR‐132/miR‐222/miR‐431 (Mw: 7.14-8.5kDa) Collagen Promote Axon Regeneration [257] miR‐132/miR‐31 (Mw: 7.14-8.5kDa) PVA Wound healing [258] Nucleic acids miR‐181a/b‐1 (Mw: 7.14-8.5kDa) PEG/PLG A Tissue engineering (osteogenesis of human mesenchymal stem cells) [259] - 33 - Antisense oligonucleotide HP-β-CD Gene suppression [260 ] Escherichia coli strain Nissle 1917 PVA/CA Probiotics delivery (gut) [261] Probiotics:Article Title: Electrospinning technologies for the delivery of Biopharmaceuticals: Current status and future trends. Article Snippet: .. - 30 - IGF-1 (Mw: 7.65kDa) HAMA/P CL Dural substitutes [238] IGF-2 (Mw: 7.5kDa) Chitosan/ PCL Wound healing [239] VEGF-A (Mw: 45kDa) PCL Neuroprotective Effects [240] TGF-β (Mw: 25kDa) PCL/PLA Tissue engineering (cardiac repair) [241] IGF-1,VEGF (Mw: 45kDa) Silk Fibroin Bone defect repair and angiogenesis [242] TGFβ3 (Mw: 25.5kDa) PCL Tissue engineering (cartilage) [243] VEGF PCL/Gela tin Tissue engineering (Patellar Ligament Regeneration) [244] SDF-1α (Mw: 8.0kDa) PLGA Trap the residual GBM cells in the brain [245] - 31 - SDF-1α/CXCL12 (Mw: 10kDa) PLA Neural Regeneration Therapy [246] TGF-β3 and SDF-1α Hyaluroni c acid Tissue engineering (articular cartilage repair) [247] Thyroid hormone triiodothyronine (Mw: 0,65kDa) (with ibuprofen) PLGA/PL LA Treatment of Acute Injuries of the Central Nervous System [248] Melatonin (Mw: 0.23kDa) PCL Tissue engineering (tendon) [249] Melatonin Chitosan/ PCL/PVA Wound healing [250] Insulin (Mw: 5.81kDa) PCL/PEO Wound healing [251] F(ab) (Mw: 50kDa) PVP Inflammatory oral mucosal disease [252] Bevacizumab (Mw: 149kDa) PCL Age-related macular degeneration [253] - 32 - Bevacizumab PCL/Gela tin Age-related macular degeneration [254] Infliximab (Mw: 144 kDa) HP-β-CD Treatment of Crohn’s disease [171] plasmid DNA (Mw: around 2000kDa) GelatinCollagenPEG Gene therapy [255] plasmid DNA Gelatin Gene therapy [256] miR‐132/miR‐222/miR‐431 (Mw: 7.14-8.5kDa) Collagen Promote Axon Regeneration [257] miR‐132/miR‐31 (Mw: 7.14-8.5kDa) PVA Wound healing [258] Nucleic acids miR‐181a/b‐1 (Mw: 7.14-8.5kDa) PEG/PLG A Tissue engineering (osteogenesis of human mesenchymal stem cells) [259] - 33 - Antisense oligonucleotide HP-β-CD Gene suppression [260 ] Escherichia coli strain Nissle 1917 PVA/CA Probiotics delivery (gut) [261] |
